BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 15, 2009
View Archived Issues
Novel calpain inhibitor Neurodur preserves postischemia retinal function in rodents
Read More
Clomiphene citrate compared to testosterone gel in retrospective hypogonadism study
Read More
Pfizer updates Q1 progress
Read More
Roche develops RO-4929097 to target Notch for tumor growth inhibition
Read More
Aminoflavone prodrug AFP-464 tested in advanced cancer patients: phase I PK/PD data presented
Read More
Data presented on novel Hsp90 inhibitors from Novartis/Vernalis collaboration
Read More
Virally derived channelrhodopsin restores visual function in adult rd1 mice
Read More
Circassia initiates phase II clinical trial with ToleroMune ragweed allergy therapy
Read More
FDA approves Takeda's ACTOplus met XR for type 2 diabetes
Read More
SuppreMol initiates dosing in phase I clinical trial of autoimmune drug SM-101
Read More
Preclinical activity of novel oncolytic agent SR-13676 described
Read More
Calcitonin gene-related peptide antagonists claimed by Boehringer Ingelheim as analgesics
Read More
AstraZeneca patents novel metabotropic glutamate mGluR5 receptor antagonists
Read More
Takeda describes novel renin inhibitors as antihypertensive agents
Read More
Multi-antigen adenovector malaria vaccine shows no protection from parasitemia in phase I/IIa trial
Read More
Novel recombinant vaccine for tuberculosis deemed safe in healthy Gambian infants
Read More
BTZ-043, a novel inhibitor of arabinan cell wall synthesis, developed as candidate for tuberculosis
Read More
Apogenix presents positive phase I APG-101 results
Read More
Banyan Biomarkers targets protein biomarkers for brain injury detection
Read More
EMEA grants approval to proceed with phase III Onalta development
Read More
FDA accepts Aridol mannitol bronchial challenge test NDA for review
Read More
Ferring reveals efficacy data for Eufelexxa in osteoarthritis knee pain
Read More
Primary endpoint achieved in phase II MDX-1100 trial for rheumatoid arthritis
Read More
Revascor shown to improve heart muscle function in phase II study
Read More
Stem Cell Therapeutics to initiate phase IIb trial of NTx-265 in acute ischemic stroke
Read More
China Aoxing acquires rights to TJSL for primary dysmenorrhea in adult women
Read More
Aegera initiates phase IIa clinical trial of AEG-33773 in diabetic peripheral neuropathy
Read More